Evidence supporting the use of: Streptomyces
For the health condition: Staph Infections

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Streptomyces, a genus of Gram-positive bacteria, is not used directly as a treatment for Staphylococcus (Staph) infections in clinical practice. However, it is of immense scientific importance due to its role as the natural source of many antibiotics, several of which are used specifically to treat Staph infections. For example, Streptomyces aureofaciens produces tetracycline, and Streptomyces griseus produces streptomycin. Most notably, Streptomyces produces aminoglycosides (e.g., gentamicin), which are often used against Staphylococcus aureus, including methicillin-resistant strains (MRSA). The discovery of these antibiotics is based on well-established scientific research and has revolutionized the treatment of bacterial infections.

Though the organism itself is not administered as a therapy, its metabolites (antibiotics) are purified and used as standard pharmaceutical agents. Numerous clinical trials and decades of use validate the efficacy of Streptomyces-derived compounds in treating Staph infections. Therefore, while Streptomyces as a bacterial genus is not a direct therapy, its products form the scientific foundation for many front-line treatments for Staph infections. The evidence supporting the use of Streptomyces-derived antibiotics against Staph infections is robust, as reflected in widespread clinical use and comprehensive studies on their mechanisms and effectiveness.

More about Streptomyces
More about Staph Infections

Products containing Streptomyces

We currently have no products on Vitabase that contain this ingredient.